PIK3CA and cancer: Hotspot mutations of PIK3CA were found in a broad scope of cancers, including melanoma, breast cancers, colorectal cancers, gastric cancers, liver cancers, etc. [4, 13], and most of these mutations have been confirmed to promote an oncogenic gain-of-function effect.